Applicant, as named in the Orange Book
Handa Therap
Next listed expiry: Phyrago on 22 Jan 2041. 1 products with live protection, 0 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Phyrago NDA 216099 · 6 strengths dasatinib | 22 Jan 2041 patent |
Recent events
- Phyrago · Generic approved · ANDA 216261, AlembicApproved 6 Nov 2025Detected 25 Oct 2026
- Phyrago · Generic approved · ANDA 219579, MsnApproved 11 Sep 2026Detected 25 Oct 2026
- Phyrago · Exclusivity expires within 90 days M-307Exclusivity expires 5 Dec 2026Detected 24 Oct 2026
- Phyrago · Exclusivity expires within 90 days M-307Exclusivity expires 5 Dec 2026Detected 24 Oct 2026
- Phyrago · Exclusivity expires within 90 days M-307Exclusivity expires 5 Dec 2026Detected 24 Oct 2026
- Phyrago · Exclusivity expires within 90 days M-307Exclusivity expires 5 Dec 2026Detected 24 Oct 2026
- Phyrago · Exclusivity expires within 90 days M-307Exclusivity expires 5 Dec 2026Detected 24 Oct 2026
- Phyrago · Exclusivity expires within 90 days M-307Exclusivity expires 5 Dec 2026Detected 24 Oct 2026